Testing effectiveness (Phase 2)Looking for participantsNCT06041503
What this trial is testing
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
Who this might be right for
Adenocarcinoma of the BladderSquamous Cell Carcinoma of the BladderTesticular Germ Cell Tumors
National Cancer Institute (NCI) 68